SMid Biotechnology Analyst Cheng, along with Dr. Robert Cooper, Endocrinologist at Holyoke Medical Center, discuss the latest development in Graves Disease (relevant companies ROIV and IMVT) on an Analyst/Industry conference call to be held on October 11 at 1 pm. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ROIV:
- Eyes on Fed ahead of expected interest rate cut: Morning Buzz
- Organon likely won’t lose money on deal with Roivant, says Evercore ISI
- Roivant divestment of Dermavant ‘great decision,’ says JPMorgan
- Roivant disposal deal good for sentiment and cash burn, says Jefferies
- Roivant Sciences Subsidiary Acquired for $1.2 Billion